DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma.

Although osteosarcoma (OS) is a rare cancer, it is the most common primary malignant bone tumor in children and adolescents. BRCAness is a phenotypical trait in tumors with a defect in homologous recombination repair, resembling tumors with inactivation of BRCA1/2, rendering these tumors sensitive t...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Maxim Barenboim, Michal Kovac, Baptiste Ameline, David T W Jones, Olaf Witt, Stefan Bielack, Stefan Burdach, Daniel Baumhoer, Michaela Nathrath
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/48d2d56a1dde466598a0484db6c4ce39
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:48d2d56a1dde466598a0484db6c4ce39
record_format	dspace
spelling	oai:doaj.org-article:48d2d56a1dde466598a0484db6c4ce392021-12-02T19:57:39ZDNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma.1553-734X1553-735810.1371/journal.pcbi.1009562https://doaj.org/article/48d2d56a1dde466598a0484db6c4ce392021-11-01T00:00:00Zhttps://doi.org/10.1371/journal.pcbi.1009562https://doaj.org/toc/1553-734Xhttps://doaj.org/toc/1553-7358Although osteosarcoma (OS) is a rare cancer, it is the most common primary malignant bone tumor in children and adolescents. BRCAness is a phenotypical trait in tumors with a defect in homologous recombination repair, resembling tumors with inactivation of BRCA1/2, rendering these tumors sensitive to poly (ADP)-ribose polymerase inhibitors (PARPi). Recently, OS was shown to exhibit molecular features of BRCAness. Our goal was to develop a method complementing existing genomic methods to aid clinical decision making on administering PARPi in OS patients. OS samples with DNA-methylation data were divided to BRCAness-positive and negative groups based on the degree of their genomic instability (n = 41). Methylation probes were ranked according to decreasing variance difference between two groups. The top 2000 probes were selected for training and cross-validation of the random forest algorithm. Two-thirds of available OS RNA-Seq samples (n = 17) from the top and bottom of the sample list ranked according to genome instability score were subjected to differential expression and, subsequently, to gene set enrichment analysis (GSEA). The combined accuracy of trained random forest was 85% and the average area under the ROC curve (AUC) was 0.95. There were 449 upregulated and 1,079 downregulated genes in the BRCAness-positive group (fdr < 0.05). GSEA of upregulated genes detected enrichment of DNA replication and mismatch repair and homologous recombination signatures (FWER < 0.05). Validation of the BRCAness classifier with an independent OS set (n = 20) collected later in the course of study showed AUC of 0.87 with an accuracy of 90%. GSEA signatures computed for this test set were matching the ones observed in the training set enrichment analysis. In conclusion, we developed a new classifier based on DNA-methylation patterns that detects BRCAness in OS samples with high accuracy. GSEA identified genome instability signatures. Machine-learning and gene expression approaches add new epigenomic and transcriptomic aspects to already established genomic methods for evaluation of BRCAness in osteosarcoma and can be extended to cancers characterized by genome instability.Maxim BarenboimMichal KovacBaptiste AmelineDavid T W JonesOlaf WittStefan BielackStefan BurdachDaniel BaumhoerMichaela NathrathPublic Library of Science (PLoS)articleBiology (General)QH301-705.5ENPLoS Computational Biology, Vol 17, Iss 11, p e1009562 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Biology (General) QH301-705.5
spellingShingle	Biology (General) QH301-705.5 Maxim Barenboim Michal Kovac Baptiste Ameline David T W Jones Olaf Witt Stefan Bielack Stefan Burdach Daniel Baumhoer Michaela Nathrath DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma.
description	Although osteosarcoma (OS) is a rare cancer, it is the most common primary malignant bone tumor in children and adolescents. BRCAness is a phenotypical trait in tumors with a defect in homologous recombination repair, resembling tumors with inactivation of BRCA1/2, rendering these tumors sensitive to poly (ADP)-ribose polymerase inhibitors (PARPi). Recently, OS was shown to exhibit molecular features of BRCAness. Our goal was to develop a method complementing existing genomic methods to aid clinical decision making on administering PARPi in OS patients. OS samples with DNA-methylation data were divided to BRCAness-positive and negative groups based on the degree of their genomic instability (n = 41). Methylation probes were ranked according to decreasing variance difference between two groups. The top 2000 probes were selected for training and cross-validation of the random forest algorithm. Two-thirds of available OS RNA-Seq samples (n = 17) from the top and bottom of the sample list ranked according to genome instability score were subjected to differential expression and, subsequently, to gene set enrichment analysis (GSEA). The combined accuracy of trained random forest was 85% and the average area under the ROC curve (AUC) was 0.95. There were 449 upregulated and 1,079 downregulated genes in the BRCAness-positive group (fdr < 0.05). GSEA of upregulated genes detected enrichment of DNA replication and mismatch repair and homologous recombination signatures (FWER < 0.05). Validation of the BRCAness classifier with an independent OS set (n = 20) collected later in the course of study showed AUC of 0.87 with an accuracy of 90%. GSEA signatures computed for this test set were matching the ones observed in the training set enrichment analysis. In conclusion, we developed a new classifier based on DNA-methylation patterns that detects BRCAness in OS samples with high accuracy. GSEA identified genome instability signatures. Machine-learning and gene expression approaches add new epigenomic and transcriptomic aspects to already established genomic methods for evaluation of BRCAness in osteosarcoma and can be extended to cancers characterized by genome instability.
format	article
author	Maxim Barenboim Michal Kovac Baptiste Ameline David T W Jones Olaf Witt Stefan Bielack Stefan Burdach Daniel Baumhoer Michaela Nathrath
author_facet	Maxim Barenboim Michal Kovac Baptiste Ameline David T W Jones Olaf Witt Stefan Bielack Stefan Burdach Daniel Baumhoer Michaela Nathrath
author_sort	Maxim Barenboim
title	DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma.
title_short	DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma.
title_full	DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma.
title_fullStr	DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma.
title_full_unstemmed	DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma.
title_sort	dna methylation-based classifier and gene expression signatures detect brcaness in osteosarcoma.
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/48d2d56a1dde466598a0484db6c4ce39
work_keys_str_mv	AT maximbarenboim dnamethylationbasedclassifierandgeneexpressionsignaturesdetectbrcanessinosteosarcoma AT michalkovac dnamethylationbasedclassifierandgeneexpressionsignaturesdetectbrcanessinosteosarcoma AT baptisteameline dnamethylationbasedclassifierandgeneexpressionsignaturesdetectbrcanessinosteosarcoma AT davidtwjones dnamethylationbasedclassifierandgeneexpressionsignaturesdetectbrcanessinosteosarcoma AT olafwitt dnamethylationbasedclassifierandgeneexpressionsignaturesdetectbrcanessinosteosarcoma AT stefanbielack dnamethylationbasedclassifierandgeneexpressionsignaturesdetectbrcanessinosteosarcoma AT stefanburdach dnamethylationbasedclassifierandgeneexpressionsignaturesdetectbrcanessinosteosarcoma AT danielbaumhoer dnamethylationbasedclassifierandgeneexpressionsignaturesdetectbrcanessinosteosarcoma AT michaelanathrath dnamethylationbasedclassifierandgeneexpressionsignaturesdetectbrcanessinosteosarcoma
_version_	1718375775825035264

DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma.

Ejemplares similares